Program Schedule

HAIs, Big Data, and National Investments in Comparative Effectiveness Research

Session: Symposium: National Gains and Future Targets for Healthcare-associated Infection Prevention
Saturday, October 11, 2014: 3:00 PM
Room: The Pennsylvania Convention Center: 113-ABC
Richard Platt, MD, MS, FSHEA, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA

Richard Platt, MD, MSc is Professor and Chair of the Department of Population Medicine at Harvard Medical School and Executive Director of the Harvard Pilgrim Health Care Institute. He is principal investigator of a CDC Prevention Epicenter, a CDC Center of Excellence in Public Health Informatics, the FDA's Mini-Sentinel program, of contracts with FDA’s Center for Drugs Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) to conduct post-marketing studies of drugs' and biologics’ safety and effectiveness, and of the AHRQ HMO Research Network DEcIDE Center. He was a SHEA Academic Councilor, chaired the FDA’s Drug Safety and Risk Management Advisory Committee, is a member of the Association of American Medical Colleges’ Advisory Panel on Research and the Institute of Medicine Roundtable on Value & Science-Driven Health Care.

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, All Rights Reserved.

Follow IDWeek